New Drug Specifically Detects Neuroendocrine Tumors – Leading to Even More Targeted Treatments

A new drug combined with leading technology provides the OSUCCC – James neuroendocrine experts with the kind of imaging that’s just not available with standard imaging techniques. Read More

A new drug combined with leading technology provides the OSUCCC – James neuroendocrine experts with the kind of imaging that’s just not available with standard imaging techniques. Read More

Working Together to Beat Endometrial Cancer

Paul Goodfellow, PhD, and David Cohn, MD, will lead The Ohio Prevention and Treatment of Endometrial Cancer (OPTEC) project and continue working to help patients with Lynch syndrome and endometrial cancer. Read More

Paul Goodfellow, PhD, and David Cohn, MD, will lead The Ohio Prevention and Treatment of Endometrial Cancer (OPTEC) project and continue working to help patients with Lynch syndrome and endometrial cancer. Read More

Once a Day Pill Puts Lung Cancer Patient Back on the Golf Course Living Life to Fullest

Marsha Harris is a self-described fitness junkie – she loves staying active. So when she started experiencing labored breathing doing normal activities, she suspected it was lingering effects of a respiratory virus. It turned out to be stage-4 lung cancer. Read More

Marsha Harris is a self-described fitness junkie – she loves staying active. So when she started experiencing labored breathing doing normal activities, she suspected it was lingering effects of a respiratory virus. It turned out to be stage-4 lung cancer. Read More